Surgalign Holdings, Inc.
- Jurisdiction
United States - ISIN
US86882C2044 (SRGA )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. Read full profile
Stock price
Fundamentals
- Net revenue
€67.31M - Gross margin
47.1% - EBIT
-€75.65M - EBIT margin
-112.4% - Net income
-€43.50M - Net margin
-64.6%
Statement period: - (published )
Dividends
No dividend payouts
Earnings Calls
Latest earnings call: May 11, 2023